GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 2 filers reported holding GENMAB A/S in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,631 | -7.2% | 188 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7,146 | +0.7% | 188 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $7,099 | -34.3% | 188 | -26.3% | 0.00% | 0.0% |
| Q4 2022 | $10,807 | +35.1% | 255 | -2.7% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | +700.0% | 262 | +1039.1% | 0.00% | – |
| Q2 2022 | $1,000 | -83.3% | 23 | -86.8% | 0.00% | -100.0% |
| Q1 2022 | $6,000 | +200.0% | 174 | +286.7% | 0.00% | – |
| Q4 2021 | $2,000 | -60.0% | 45 | -57.9% | 0.00% | -100.0% |
| Q3 2021 | $5,000 | +150.0% | 107 | +7.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | -90.9% | 100 | -90.0% | 0.00% | -80.0% |
| Q4 2019 | $22,000 | +10.0% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $20,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |